Core Laboratories (CLB) Non-Current Debt (2022 - 2026)

Core Laboratories has reported Non-Current Debt for 5 years, with the latest figure at $114.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 7.97% year-over-year to $114.5 million; the trailing twelve-month figure through Mar 2026 stood at $114.5 million (down 7.97% YoY), and the FY2025 full-year result was $110.3 million, down 12.57% from the prior year.
• Non-Current Debt for Q1 2026 stood at $114.5 million, up from $110.3 million in the prior quarter.
• The five-year high for Non-Current Debt was $182.6 million in Q2 2023, with the low at $110.3 million in Q4 2025.
• Historically, Non-Current Debt has averaged $142.9 million across 5 years, with a median of $139.9 million in 2024.
• Annual changes were most pronounced in 2023 — Non-Current Debt decreased 5.37% — and 2024, when it retreated 22.69%.
• Core Laboratories' Non-Current Debt stood at $172.4 million in 2022, then slipped by 5.37% to $163.1 million in 2023, then slipped by 22.69% to $126.1 million in 2024, then retreated by 12.57% to $110.3 million in 2025, then grew by 3.81% to $114.5 million in 2026.
• The last three Non-Current Debt figures came in at $114.5 million (Q1 2026), $110.3 million (Q4 2025), and $114.1 million (Q3 2025), per Business Quant data.